Den højere forekomst af dødsfald var ikke relateret til olanzapindosis (gennemsnitlig daglig dosis, 4, 4 mg) eller behandlingsvarighed.
The higher incidence of death was not associated with olanzapine dose (mean daily dose 4.4 mg) or duration of treatment.